ATTENTION SAVA SHAREHOLDERS: Investors who Lost Money on Cassava Sciences, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Cassava Sciences, Inc. for potential violations of federal securities laws following the announcement that their Phase 3 ReThink-ALZ study did not meet its endpoints.
November 27, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cassava Sciences is under investigation by Levi & Korsinsky for potential securities law violations after their Alzheimer's drug trial failed to meet endpoints.
The investigation by Levi & Korsinsky into Cassava Sciences for potential securities law violations is likely to negatively impact the stock price. The failure of the Phase 3 trial to meet its endpoints is a significant setback for the company, which could lead to decreased investor confidence and potential legal repercussions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100